Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2016 Jun 23;25(7):1018–1028. doi: 10.1158/1055-9965.EPI-16-0121

Adherence to Diet and Physical Activity Cancer Prevention Guidelines and Cancer Outcomes: A Systematic Review

Lindsay N Kohler 1, David O Garcia 1, Robin B Harris 1, Eyal Oren 1, Denise J Roe 1,2, Elizabeth T Jacobs 1,2,3
PMCID: PMC4940193  NIHMSID: NIHMS791625  PMID: 27340121

Abstract

Many studies have reported that adherence to health promotion guidelines for diet, physical activity, and maintenance of healthy body weight may decrease cancer incidence and mortality. A systematic review was performed to examine associations between adherence to established cancer prevention guidelines for diet and physical activity and overall cancer incidence and mortality. PubMed, Google Scholar, and Cochrane Reviews databases were searched following the current recommendations of Preferred Reporting Items for Systematic Reviews and Meta-analysis Approach (PRISMA). Twelve studies met inclusion criteria for this review. High versus low adherence to established nutrition and physical activity cancer prevention guidelines was consistently and significantly associated with decreases of 10% to 61% in overall cancer colorectal cancer incidence in both men and women (27%-52%). Consistent significant reductions were also shown for breast cancer incidence (19-60%), endometrial cancer incidence (23-60%), and colorectal cancer incidence in both men and women (35-52%). Findings for lung cancer incidence were equivocal and no significant relationships were found between adherence and ovarian or prostate cancers. Adhering to cancer prevention guidelines for diet and physical activity is consistently associated with lower risks of overall cancer incidence and mortality, including for some site-specific cancers.

Keywords: adherence, cancer incidence, cancer prevention guidelines, diet, physical activity

Introduction

An estimated 1,685,210 new cancer diagnoses and 595,690 cancer deaths are expected in the United States (U.S.) in 2016 (1). Behaviors such as poor diet choices, physical inactivity, excess alcohol consumption and unhealthy body weight could account for more than 20% of cancer cases and therefore be prevented with lifestyle modifications (1). Two-thirds of U.S. cancer deaths can also be attributed to these modifiable behaviors when including exposure to tobacco products (2-6).

To help guide individuals and communities toward healthier lifestyles, nutrition and physical activity guidelines for cancer prevention have been designed by the U.S. Department of Health and Human Services along with leading health organizations such as the American Cancer Society (ACS) (7) and the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) (8). These cancer prevention and health promotion guidelines focus on specific lifestyle recommendations to 1) achieve and maintain a healthy weight throughout life; 2) adopt a physically active lifestyle; 3) consume a healthy diet with an emphasis on plant-based foods; and 4) limit alcohol consumption (2).

Often epidemiological studies attempt to parse out specific, individual risk factors; however, examination of an overall risk pattern also provides key information when considering health-related behaviors which often co-occur (9). For example, a general risk profile pattern can be ascertained by measuring adherence to cancer prevention guidelines. A score can be constructed based on multiple lifestyle aspects including body mass index (BMI), physical activity, alcohol intake, and various aspects of a healthy diet such as intake of fruit and vegetables, whole grains, and red/processed meat. Utilization of such an adherence score would allow for investigation of overall behavior patterns.

The ACS and WCRF/AICR examine the most current, evidence-based research on diet, physical activity, and cancer risk from laboratory experiments, human studies, and comprehensive reviews, and then publish cancer prevention recommendations for individuals and community action. The most recent update from the ACS Nutrition and Physical Activity Guidelines Advisory Committee was published in 2012 (2). The ACS guidelines contain specific strategies to adhere to the aforementioned recommendations. Similarly, WCRF/AICR guidelines focus on improving modifiable risk profiles, with the most recently-published recommendations for healthy lifestyles in 2007 (4). These recommendations also proffer guidelines for remaining as lean as possible within the normal range of body weight, being physically active as a part of everyday life, eating mostly plant foods, limiting intake of red meat and avoiding processed meat, limiting consumption of alcohol, limiting consumption of energy dense foods, avoiding sugary drinks, and limiting salt consumption.

The aim of the systematic review was to synthesize the evidence from prospective cohort studies regarding adherence to the ACS and WCRF/AICR nutrition and physical activity cancer prevention guidelines and the risk of overall cancer incidence and/or cancer mortality.

Methods and Materials

Search Strategy and Identification of Studies

Two independent authors (LNK, DOG) executed the following comprehensive search strategy following the current recommendations of Preferred Reporting Items for Systematic Reviews and Meta-analysis Approach (PRISMA) (10). Key search terms were used to maximize the identification of prospective cohort studies that examined associations between adherence to nutrition and physical activity cancer prevention guidelines and cancer incidence and mortality. Databases were searched in March 2016, using the following search parameters: PubMed key terms “cancer prevention guidelines”, “nutrition,” physical activity,” “adherence,” “cancer incidence and/or cancer mortality”; Google Scholar search “cancer prevention guideline adherence AND nutrition AND physical activity AND cancer incidence” with the exact phrase “cancer prevention guidelines” and at least one of the words “incidence mortality”; and Cochrane reviews strategy “adherence to nutrition physical activity cancer prevention guidelines”. Filters included human studies in English only, articles that had full text available; and papers published within the past ten years. All eligible full-text articles selected for inclusion were examined for citations of relevant studies.

Titles and abstracts were screened by two reviewers; data were extracted by one reviewer (LNK) and double-checked by the second reviewer (DOG) using a pre-designed data extraction form. Data extracted from each study included the author’s first and last names, title, publication year, study population (cohort and sample size), follow-up period, guidelines utilized and how adherence score was generated, covariates, and study outcomes including relative risks (RR) or hazard ratios (HR) and confidence intervals (CI). The Critical Appraisal Skills Programme’s Making sense of evidence (11) was the predetermined tool used to assess the risk of bias. The tool was used to assess recruitment procedures, measurement of exposure, confounding variables, study outcomes, and generalizability. A third reviewer (ETJ) resolved any disagreement. The protocol was registered with PROSPERO International Prospective Register of systematic reviews (Ref: CRD42015026614).

Inclusion and exclusion criteria

Only prospective cohort studies were eligible for inclusion as the focus was to ascertain cancer incidence and cancer mortality. Minimally, studies must have collected data for physical activity and diet, generated an adherence score based on either ACS or WCRF/AICR cancer prevention guidelines (2, 12), and reported cancer outcomes of incidence and/or mortality in order to be deemed eligible for this review. Overall cancer incidence and cancer mortality were the primary outcomes of interest. However, site-specific cancer risks were also considered when data were available from at least two studies meeting the eligibility criteria. Commentaries and summary documents were excluded unless they presented additional data.

Results

A total of 2,033 potentially relevant studies were reviewed; after removal of duplicates and exclusion on the basis of title or abstract, 25 full papers on nutrition and physical activity cancer prevention guideline adherence were retained for in-depth consideration. The selection process for the articles is shown in Figure 1. We identified 12 manuscripts that met the a priori criteria for inclusion (Table 1). These studies represented analyses of data from 10 cohorts including the Cancer Prevention Study-II (CPS-II) nutrition cohort (13), the Women’s Health Initiative (WHI) cohort (14), the National Institutes of Health-American Association of Retired Persons (NIH-AARP) Diet and Health Study cohort (15), the Framingham Offspring (FOS) cohort (16), the Vitamins and Lifestyle (VITAL) Study cohort (17), the Canadian National Breast Screening Study (NBSS) (18), the Swedish Mammography Cohort (SMC) (19), the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort (20, 21), the Southern Community Cohort Study (SCCS) (22), and the Iowa Women’s Health Study (IWHS) cohort (23). Adherence scores for these studies were constructed utilizing recommendations from the American Cancer Society (ACS) (Table 2) (7) or the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) (Table 3) (8).

Figure 1. Article selection process.

Figure 1

The PRISMA diagram details the search and selection of manuscripts for the review.

Table 1.

Characteristics and findings of included prospective studies.

Author, year Study name, data collection years, sample
size, years follow-up, guidelines
Relevant Outcome(s) Key Findings
1 McCullough,
2011
CPS-II Nutrition Cohort, 1992-1993,
n=111,966, 14 years, ACSi-8 point score
All cancer mortality Men: RRii=0.70, 95% CIiii: 0.61-0.80
Women: RR=0.76, 95% CI: 0.65-0.89
2 Thomson,
2014
Women’s Health Initiative, 1993-1998,
n=65,838, 12.6 years, ACS-8 point score
All cancer incidence,
and mortality, site-
specific cancer
incidence
Cancer incidence: HRiv=0.83, 95% CI: 0.75-0.92
Cancer mortality: HR=0.80, 95% CI: 0.71-0.90
Colorectal: HR=0.48, 95% CI: 0.32-0.73
Breast: HR=0.78, 95% CI: 0.67-0.92
Endometrial: HR=0.73, 95% CI: 0.49-1.09
Ovarian: HR=1.13, 95% CI: 0.68-1.87
Lung: HR=1.14, 95% CI: 0.81-1.60
3 Kabat, 2015 NIH-AARP Diet and Health Study, 1995-1996,
n=476,396, 10.5-12.6 years, ACS-11 point
score
All cancer incidence,
site-specific cancer
incidence, all cancer
mortality
All cancer incidence:
Men HR=0.90, 95% CI: 0.87-0.93
Women HR=0.81, 95% CI: 0.77-0.84
All cancer mortality:
 Men HR=0.75, 95% CI: 0.70-0.80
 Women HR=0.76, 95% CI: 0.70-0.83
Colon:
 Men HR=0.52, 95% CI: 0.47-0.59
 Women HR=0.65, 95% CI: 0.54-0.78
Rectal:
 Men HR=0.60, 95% CI: 0.51-0.72
 Women HR=0.64, 95% CI: 0.49-0.83
Lung:
 Men HR=0.85, 95% CI: 0.78-0.93
 Women HR=0.94, 95% CI: 0.84-1.05
Breast: HR=0.81, 95% CI: 0.76-0.87
Endometrial: HR=0.40, 95% CI: 0.34-0.46
Ovarian: HR=0.95, 95% CI: 0.73-1.23
5 Hastert, 2013 VITAL cohort, 2000-2002, n=30,797 post-
menopausal women, 7.7 years, WCRF/AICR
Met/didn’t meet
Breast cancer
incidence
HR=0.40, 95% CI 0.25-0.65
4 Hastert, 2014 VITAL cohort, 2000-2002, n=57,841, 7.7 years,
WCRF/AICR met/didn’t meet
All cancer mortality HR=0.39, 95% CI 0.24-0.62)
Makarem,
2015
FOS cohort, 1991, n=2,983, 11.5 years,
WCRF/AICR 7 point score
Incidence of obesity-
related cancers and
site-specific: breast,
prostate, and colon
Obesity-related: HR=0.94, CI 0.86-1.02
Breast: HR=0.87, 95% CI: 0.74-1.03
Prostate: HR=1.08, 95% CI: 0.92-1.27
Colorectal: HR=0.87, 95% CI: 0.68-1.12
7 Harris,
2016
SMC, 1987-1990, n=31,514, 15 years,
WCRF/AICR 7 point score
Breast cancer
incidence
HR=0.49, 95% CI: 0.35-0.70
8 Catsburg,
2014
Canadian NBSS, 1980-1985, n=47,130
WCRF/AICR and n=46,298 ACS, 16.6 years
Breast cancer
incidence
ACS: HR=0.69, 95% CI: 0.49-0.97
WCRF/AICR: HR= 0.69, 95% CI: 0.47-1.00
9 Vergnauad,
2013
EPIC Study, 1992-2000, n=378,864, 12.8 years,
WCRF/AICR 6 point score for men, 7 point
score for women
All cancer mortality Total: HR=0.80, 95% CI: 0.69-0.93
Men: HR=0.86, 95% CI: 0.69-1.07
Women: HR=0.76, 95% CI: 0.62-0.93
10 Romaguera,
2012
EPIC Study, 1992-2000, n=386,355, 11.0 years,
WCRF/AICR 6 point score for men, 7 point
score for women
All cancer incidence,
site-specific cancer
incidence
All cancer incidence:
 Men HR=0.84, 95% CI: 0.72-0.99
 Women HR=0.81, 95% CI: 0.72-0.91
Colorectal: HR=0.73, 95% CI: 0.65-0.81
Lung: HR=0.86, 95% CI: 0.74-1.00
Breast: HR= 0.84, 95% CI: 0.78-0.90
Endometrial: HR= 0.77, 95% CI: 0.62-0.94
Ovarian: HR= 0.99, 95% CI: 0.79-1.25
Prostate: HR=1.02, 95% CI: 0.91-1.14
11 Nomura, 2016 IWHS, 1986, n=36,626 post-menopausal, >23
years, WCRF/AICR 8 point score
Breast cancer
incidence
HR=0.76, 95% CI: 0.67-0.87
12 Warren
Andersen,
2016
SCCS, 2002-2009, n=61,098 low-income
racially diverse adults, 6 years, ACS 4 point
score
All cancer incidence HR=0.96, 95% CI: 0.65-1.42v
HR=0.55, 95% CI: 0.31-0.99vi
i

American Cancer Society

ii

Relative Risk

iii

Confidence Interval

iv

Hazard Ratio

v

Total analytic population. P-trend 0.09

vi

Participants without chronic disease at baseline. P-trend 0.003

Table 2.

ACS recommendations and adherence score breakdown of selected studies.

American Cancer Society
Recommendation McCullough, 2011
Thomson, 2014vii
Kabat, 2015 Catsburg, 2014 Warren Andersen, 2016
“Maintain a healthy weight
throughout life”
0: Obese at both time points or
obese at 1 and overweight at the
other
1: All others
2: BMIviii 18-<25 at both times
0: >35.0
1: 30-34.9
2: 25-29.9
3: 18.5-24.9
18.5 ≤ BMI ≤25 18.5 ≤ BMI ≤25
“Adopt a physically active
lifestyle”
0: <8.75 METix h/wk
1: 8.75-17.5 MET h/wk
2: >17.5 MET h/wk
0: ≤ 3x/mo
1: 1-2x/wk
2: 3-4x/wk
3: ≥5x/wk
≥ 150 min/week ≥ 150 min/wk of
moderate, ≥ 75 min/wk of
vigorous or ≥ 150 min/wk
of moderate + vigorous
“Eat 5 or more servings of a variety
of vegetables and fruits each day”
1: ≥5 servings/d fruits +veg
+1 or 2 “variety” points for 2nd
or 3rd tertile of unique fruits or
veg consumed/month
Quartiles >400g vegetables and
fruit per day
≥2.5 cups vegetables +
fruits/d
“Choose whole grains instead of
refined grains”
Quartiles of the ratio
of whole grains to
total grains
Quartiles of the ratio
of whole grains to
total grains
Ratio of whole:
refined grains >1
Highest quartile of the
ratio of whole grains to
total grains
“Limit consumption of processed
and red meats”
Quartiles of red + processed
meat intake (servings/wk)
Quartiles of red +
processed meats
<500g red and
processed meat per
week
Lowest quartile of red +
processed meats
“If you drink, limit consumption
to 1 drink/day for women or 2
drink/day for men”
Women:
0: >1
1: >0-≤1
2: Non
Men:
0: >2
1: >0-≤2
2: Non
Women:
0: ≥2
1: Non
2: 1
Men:
0: ≥3
1: Non
2: 1-2
≤1 standard drink/d Women ≤1 drink/d
Men ≤2 drinks/d
vii

Thomson evaluated BMI as <18.5 excluded 0: BMI >=30 kg/m2 at age 18 or at baseline, 1: BMI 25-<30 at age 18 or baseline, 2: BMI <25 kg/m2 at age 18 and baseline; diet score plus 1 or 2 “quality” points for being in the 2nd or 3rd tertile of total carotenoids; alcohol score 2 points for nondrinker at baseline

viii

Body mass index, kg/m2

ix

Metabolic Equivalent of Task

Table 3.

WCRF/AICR recommendations and adherence score breakdown of selected studies.

World Cancer Research Fund/American Institute for Cancer Research
Recommendation Hastert, 2013 &
2014x
Catsburg, 2014 Makarem, 2015 Harris, 2016 Vergnaud, 2013
Romaguera, 2012
Nomura, 2016
“Be as lean as possible
within the normal range
of body weight”
18.5 ≤ BMIxi <25 18.5 ≤ BMI ≤25 0: <18.5 BMI
>30.0
0.5: 25-29.9
1: 18.5-24.9
18.5 ≤ BMI
<25
0: <18.5 BMI >30.0
0.5: 25-29.9
1: 18.5-24.9
0: <18.5 BMI
≥30.0
0.5: 25-<30
1: 18.5-<25
“Be physically active as
part of everyday life”
≥30 min/d of
moderate/fast
walking and/or
moderate/strenuo
us activity ≥5
days/wk in ≥7 of
the past 10 yrs
≥210 min/wk 0: <30 PAIxii
0.5: 30-33
1: >33
≥30 min/dxiii 0: <15 min/dxiv
0.5: 15-30 min/dv
1: Manual/heavy manual job, or
>2h/wk vigorous, or
>30 min/dv
0: all other
0.5: 2-4x/wk
moderate or 1x/wk
vigorous
1: ≥2x/wk
vigorous or
≥5x/wk moderate
“Eat mostly foods of
plant origin”
≥5 servings of
fruits + veg and
≥1 serving whole
grains and/or
legumes/d
>400g veg +fruit
plus ≥25g whole
grains +
legumes/d
Fruit + Veg
(servings/d)
0: <2.5
0.5: 2.5-<5
1: ≥5

Refined Grains
(g/d)
Tertiles

Vegetables
(g/week)
0: Sxv>503;
NSxvi <2,471.4 or
S>503; NS
>2,471.4
0.5: S<503;
NS>2,471.4
1: S<503;
NS>2,471.4
>400g veg +
fruit plus ≥25g
whole grains
and legumes/d
Fruit + Veg (g/d)
0: <200
0.5: 200 to <400
1: >400

Dietary Fiber (g/d)
0: <12.5
0.5: 12.5 to <25
1: ≥25
Fruit + Veg
(servings/d)
0: <3
0.5: 3-<5
1: ≥5

Dietary Fiber (g/d)
0: <12.5 0.5: 12.5 to <25
1: ≥25
“Limit intake of red meat
and avoid processed
meat”
<18 oz red and/or
processed meat
per week
<500g red and
<25g processed
meat per week
0: ≥500 g/wk or
≥50 g/d
0.5: <500 g/wk &
3 to <50 g/d
1: <500 g/wk &
<3 g/d
<500g red and
<25g processed
meat/wk
0: ≥500 g/wk or ≥50
g/d
0.5: <500 g/wk & 3
to <50 g/d
1: <500 g/wk & <3
g/d
0: ≥500 g/wk
RPxvii or ≥50 g/wk
Pxviii
0.5: <500 g/wk RP
& 3 to <50 g/wk P
1: <500 g/wk RP &
<3 g/wk P
“Limit alcoholic drinks” ≤1 drink/d for
women; ≤2
drink/d for men
≤1 standard
drink per day
Wome
n
g/day:
0: >21
0.5: 14-
24 1: ≤14
Men
g/day:
0: >42
0.5: 28-
42
1: ≤28
<10g alcohol/d Women
g/d:
0: >20
0.5: >10-
20 1: ≤10
Men
g/d:
0: >30
0.5:
>20-30
1: ≤20
0: >20 g/d
0.5: >10-20
1: ≤10
“Limit consumption of
EDxix foods; avoid
sugary drinks”
ED of diet <125
kcal/100g or <1
sugary drink/wk
ED of food
<125kcal/100g.
No soda or
drinks with
added sugar
ED Foods
(servings/wk)
Tertiles
<14
servings/wk of
ED foods and
<2 glasses/d of
soda/juice
0: ED: >175xx
0.5:>125 to <175
1: ≤125
0: >250 g/d sugary
drink
0.5: ≤250 g/d
1: 0 g/d
0: ≥250 g/d
sugary
drink
0.5: <250 g/d
1: 0 g/d
“Limit consumption of
salt”
Not included <2.4g sodium/d Salty Foods
Tertiles
Sodium Intake g/d
0: >3.6
0.5: 2.4-3.6
1: <2.4
Not included Not included 0: >2400 mg/d
0.5: >1500-2400
mg/d
1: ≤1500 mg/d
“Dietary supplements not
recommended for cancer
prevention”
Not included Not included Not included Did not report
consuming on a
regular basis
Not included Not included
“Mothers to breastfeed” Not included Not included Not included Not included 0: No BFxxi
0.5: >0 to <6
months
1: ≥6 months
Not included
x

Hastert 2014 evaluated both men and women

xi

Body Mass Index kg/m2

xii

Physical Activity Index

xiii

Walking/cycling + leisure time exercise

xiv

Cycling or sports

xv

Starchy vegetable

xvi

Non-starchy vegetable

xvii

Red and processed meat

xviii: Processed meat

xix

Energy dense/density

xx

kcal/100g/day

xxi

Breastfeeding

Overall Cancer

Seven studies evaluated the association between guideline adherence for diet, physical activity, healthy body weight, and alcohol consumption and overall cancer incidence and/or mortality. After adjustment for covariates, there were statistically significant effects of guideline adherence on cancer risk. Participants with high adherence to the ACS guidelines were less likely to develop or die from any cancer compared to those participants that had low adherence to the ACS guidelines (24-27). Likewise, meeting or highly adhering to WCRF/AICR recommendations versus low or no adherence to the recommendations also demonstrated statistically significant risk reduction in overall cancer incidence (28) and mortality (29, 30).

The study by McCullough et al. (24) developed an original scoring system to reflect adherence to the ACS guidelines with the goal of evaluating the association between following the recommended guidelines and risk of death from cancer, cardiovascular disease, and all causes. The authors evaluated 111,966 non-smoking men and women in the CPS-II Nutrition cohort, which is a subset of the larger CPS-II (13). Participants were primarily healthy, Caucasian adults aged 50-74 years from 21 states in the U.S. (13). The scoring system weighted each recommendation equally from 0 to 2 possible points, with 0 points representing not meeting the recommendation at all, 1 point for partially meeting the recommendation, and 2 points for fully meeting the recommendation. The overall adherence scores in the study population ranged from 0 for those participants who did not follow any of the guidelines to 8 for those participants that were fully adherent to all four lifestyle factor recommendations (Table 2). High adherence was a score of 7-8 points and low adherence was a score of 0-2 points. McCullough et al. reported a 24% reduction (RR=0.76, 95% CI: 0.65-0.89) and a 30% reduction (RR=0.70, 95% CI: 0.61-0.80) in cancer mortality over 14 years of follow up for men and women, respectively, with high adherence compared to those with low adherence to the ACS guidelines. (24).

Thomson et al. (25) used similar methodology to examine the impact of adherence to the ACS guidelines in 65,838 postmenopausal women aged 50-79 years from the Women’s Health Initiative Observational Study (WHI-OS) (14). The WHI-OS was a prospective study of health outcomes in postmenopausal women that were enrolled in 40 U.S. clinical centers from 1993 to 1998 (31). Overall baseline adherence scores were similar to those from the CPS-II cohort, differing only slightly. The recommendation to “maintain a healthy weight throughout life” was assessed from reported weight at 18 years and measured at study baseline. The score for the recommendation to “consume a healthy diet with an emphasis on plant sources” included an extra point or two for diet quality determined by being in the second or third tertile of total carotenoids, respectively (Table 2). Similar to the previous study, the overall adherence scores ranged from 0 for those participants not adherent to any of the guidelines to 8 for fully adherent participants and were collapsed into categories for comparison. The overall cancer incidence or mortality analyses included a comparison of highly adherent participants with a score of 7 or 8 compared to low adherence participants scoring less than 2 points. Cancer-specific mortality analyses further collapsed categories of the score (0-3, 4-5, 6-8) due to smaller numbers of events. In women that had high adherence to the ACS guidelines, Thomson et al. demonstrated a 17% reduction in cancer incidence over the 12.6 years of follow-up (HR=0.83, 95% CI: 0.75-0.92) and 20% reduction in cancer-specific mortality (HR=0.80, 95% CI: 0.71-0.90) compared to women with low adherence to the ACS guidelines (25).

In the third study utilizing the ACS guidelines, nearly half a million men and women aged 50-71 in the NIH-AARP Diet and Health Study (n=476,396) were included from 6 states and 2 metropolitan areas with existing population-based cancer registries from 1995-1996 (15). Adherence scores were modified somewhat from prior ACS-based studies by using only one baseline measurement for BMI, categorizing physical activity by times per week instead of metabolic equivalents of task (MET) hours per week, not including a variety or quality of diet measure, and giving moderate drinkers (1-2 drinks per day for men and 1 drink per day for women) the most adherent score of 2 points for the alcohol consumption recommendation (Table 2). Participants were categorized as most adherent if they scored 8-11 points and least adherent if they scored 0-3 points overall. As shown in Table 1, Kabat et al. reported a statistically significant decrease in cancer incidence over the 10.5 years of follow-up for both highly adherent men (HR=0.90, 95% CI: 0.87-0.93) and women (HR=0.81, 95% CI: 0.77-0.84). A statistically significant reduction in cancer mortality was also reported during the 12.6 years of follow-up for both highly adherent men (HR=0.75, 95% CI: 0.70-0.80) and women (HR=0.76, 95% CI: 0.70-0.83) (27).

Warren Andersen et al. (26) performed the most recent evaluation between adherence to the ACS guidelines and overall cancer incidence utilizing the Southern Community Cohort Study (SCCS) (n=61,098) with a focus on representing low-income Whites and African Americans in the southeastern United States. Adherence scores ranged from 0 to 4 points with 1 point assigned for each recommendation met upon study entry (Table 2). A comparison of the most adherent participants (score=4) versus non-adherent participants (score=0) demonstrated a nonsignificant 4% reduction in overall cancer incidence (HR=0.96, 95% CI: 0.65-1.42) in the SCCS participants. However, when evaluating only participants free of chronic disease at baseline, a statistically significant 45% reduction in cancer risk (HR=0.55, 95% CI: 0.31-0.99) was found (26).

Romaguera et al. (28) assessed the association between adherence to WCRF/AICR guidelines and overall cancer incidence as well as specific types of cancer incidence in the European Prospective Investigation into Nutrition and Cancer (EPIC) cohort study (n=386,355) (20, 21). The constructed adherence score (Table 3) operationalized the WCRF/AICR recommendations of body fatness, physical activity, intake of food and drinks that promote weight gain, intake of plant foods, intake of animal foods, intake of alcoholic drinks, and breastfeeding. One point was assigned for each recommendation that was fully met, a half point was assigned for partially meeting the recommendation, and all others received zero points for not meeting the recommendation. For women, high adherence to the score was denoted if the score summed to 6-7 points compared to low adherence scoring 0-3 points. For men, high adherence was considered a score of 5-6 compared to low adherence scoring 0-2 points. Romaguera et al. reported a statistically significant decrease in overall cancer incidence over the 11.0 years of follow-up for both highly adherent men (HR=0.84, 95% CI: 0.72-0.99) and women (HR=0.81, 95% CI: 0.72-0.91). In addition, a 1-point increment of the adherence score was associated with a statistically significant 5% reduction in overall cancer incidence (HR=0.95, 95% CI: 0.93-0.97) (28).

Similarly, Vergnaud et al. (30) investigated whether adherence to WCRF/AICR recommendations was associated with risk of death in the EPIC cohort study (n=378,864) after a median follow-up time of 12.8 years (20, 21). The adherence score (Table 3) was modeled after the previous work of Romaguera et al. utilizing the same recommendations and collapsing the score into the same sex-specific high and low adherence categories. A significant reduction in cancer-specific mortality was found among women who were most adherent to WCRF/AICR recommendations (HR=0.76, 95% CI: 0.62-0.93). Statistical significance was not reached in the association for men (HR=0.86, 95% CI: 0.69-1.07); however, an 8-9% reduction in risk per 1-point increase of WCRF/AICR adherence score was statistically significant for both men (HR=0.92, 95% CI: 0.89-0.95) and women (HR=0.91, 95% CI: 0.88-0.94) (30).

Finally, Hastert et al. (2014) also operationalized the WCRF/AICR guidelines (Table 3) to examine the association between meeting guidelines on nutrition and physical activity and cancer mortality in a cohort of men and women (n=57,841) aged 50 to 76 years from the VITAL study (17). Adherence to the WCRF/ AICR guidelines was classified as met or did not meet (DNM) for each of the 6 included recommendations (Table 2). Recommendations to limit salt preserved foods and supplements were not considered as the former was not considered common in the U.S. food supply and the latter because the guidelines did not recommend for or against supplementation for the prevention of cancer. Adherence was measured as follows: BMI by self-reported height and weight, physical activity by minutes per day and intensity, energy density, plant foods, red meat, and alcohol based on responses to the food frequency questionnaire (FFQ). Meeting at least five recommendations compared to meeting none demonstrated a 61% reduction in cancer-specific mortality over 7.7 years of follow-up (HR=0.39, 95% CI: 0.24-0.62) (29).

Breast Cancer

In addition to overall cancer incidence, eight studies reported results for female breast cancer incidence as an outcome (25, 27, 32-35). Consistent reductions in breast cancer incidence were demonstrated in the WHI, NIH-AARP, and EPIC cohorts for high adherence to nutrition and physical activity cancer prevention guidelines versus low adherence, with HRs (95% CIs) of HR=0.78, 95% CI: 0.67-0.92 (25), HR=0.81, 95% CI: 0.76-0.87 (27), and HR=0.84, 95% CI: 0.78-0.90, respectively (28). Hastert et al. also investigated breast cancer incidence as an outcome using the WCRF/AICR guidelines in a cohort of postmenopausal women aged 50 to 76 years from the VITAL study (n = 30,797). Meeting at least five WCRF/AICR recommendations compared with meeting none was associated with a 60% reduction in breast cancer incidence (HR: 0.40, 95% CI: 0.25-0.65). Furthermore, each additional recommendation met was associated with an 11% reduction in breast cancer risk (HR=0.89, 95% CI: 0.84-0.95). (32). Similarly, Harris et al. demonstrated a 51% reduction in breast cancer incidence (HR: 0.49, 95% CI: 0.35-0.70) (33) for those most adherent (score≥6) compared to least adherent (score ≤2) to the WCRF/AICR guidelines in the primarily post-menopausal women in the Swedish Mammography Cohort (SMC) (n=31,514) that were followed for 15 years (19). Makarem et al. (36) also used the WCRF/AICR guidelines to examine the relationship between meeting the recommendations and obesity-related cancer incidence in a sample of men and women from the Framingham Offspring (FOS) cohort (n=2,983) (16). Cancers were considered obesity-related if clearly or possibly linked to excess adiposity by the ACS. Participants received 1, 0.5, or 0 points for fully meeting, partially meeting or not meeting the WCRF/AICR recommendation, respectively (Table 2). Similar to the VITAL study, hazard ratios for every 1-unit increment in the overall adherence score were computed for obesity-related cancers and site-specific cancers. Conversely, no statistically significant association was found between adherence and breast cancer incidence (HR=0.87, 95% CI: 0.74-1.03) on a per-recommendation basis (36). Catsburg et al. (34) operationalized both ACS and WCRF/AICR guidelines in the Canadian National Breast Screening study (NBSS) (n=47,130 WCRF, n=46,298 ACS)(18). Adherence to all six ACS guidelines compared to at most one guideline was associated with a statistically significant 31% reduction in breast cancer incidence (HR=0.69, 95% CI: 0.49-0.97). Adhering to six or seven WCRF/AICR guidelines compared to at most one guideline was associated with a 21% reduction in risk (HR=0.79, 95% CI: 0.57-1.10) but did not reach statistical significance. Meeting each additional guideline was associated with a 5% (HR=0.95, 95% CI: 0.91-0.98) or 6% (HR=0.94, 95% CI: 0.91-0.98) reduction in breast cancer incidence utilizing the WCRF/AICR and ACS recommendations, respectively (34). Most recently, Nomura et al. (35) evaluated adherence to the WCRF/AICR guidelines and breast cancer incidence among postmenopausal women with and without non-modifiable risk factors in the Iowa Women’s Health Study (IWHS) (n=36,626). The eight point adherence score was collapsed into 4 categories: 0-3.5 points (low adherence), 4.0-4.5, 5.0-5.5, 6.0-8.0 (high adherence). High adherence compared to low adherence to WCRF/AICR guidelines was significantly associated with a reduction in breast cancer incidence (HR=0.76, 95% CI: 0.67-0.87) (35).

Colorectal Cancer

A total of four studies reported results for colorectal cancer specifically (25, 27, 28, 36). Significant inverse associations were found between adherence to ACS guidelines and colorectal cancer incidence in the WHI cohort (HR=0.48, 95% CI: 0.32-0.73) (25) as well as the NIH-AARP cohort for women (HR=0.65, 95% CI: 0.54-0.78) and men (HR=0.52, 95% CI: 0.47-0.59) (27). Consistently, a statistically significant reduction in colorectal cancer was associated with higher adherence in the EPIC cohort (HR=0.73, 95% CI: 0.65-0.81) (28). In contrast, the FOS cohort demonstrated no significant association for colorectal cancer incidence and adherence to WCRF/AICR guidelines (HR=0.87, 95% CI: 0.68-1.12) (36).

Lung Cancer

The association between ACS guideline adherence and lung cancer incidence is equivocal. Three studies reported results for the association between nutrition and physical activity guideline adherence and lung cancer incidence (25, 27, 28). In the NIH-AARP cohort, effect modification by sex was demonstrated with a statistically significant inverse association found among highly adherent men (HR=0.85, 95% CI: 0.78-0.93), but not highly adherent women (HR=0.94, 95% CI: 0.84-1.05) (27). Results from the WHI are consistent with these reporting no statistical significance between lung cancer incidence in women and ACS guideline adherence (HR=1.14, 95% CI: 0.81-1.60) (25). The association between high adherence and lung cancer incidence was not statistically significant when evaluated for both sexes combined in the EPIC study (HR=0.86, 95% CI: 0.74-1.00) (28).

Endometrial Cancer

To date, three prospective studies have reported results for the association between nutrition and physical activity guideline adherence and endometrial cancer incidence. The large NIH-AARP and EPIC cohorts both found significant inverse associations demonstrated by higher adherence and lower risk of endometrial cancer (HR=0.40, 95% CI: 0.34-0.46; HR=0.77, 95% CI: 0.62-0.94), respectively (27, 28); while findings from the WHI cohort suggest no significant association (HR=0.73, 95% CI: 0.49-1.09) (25). Although analysis of the adherence score as a categorical variable (high vs. low) in the latter study was not statistically significant for risk of endometrial cancer, the overall trend using ACS score as an ordinal variable (0-8 points) suggested a significant 7% reduction in endometrial cancer incidence (HR=0.93, 95% CI: 0.87-0.98) (25).

Other Cancers

Data were also available from three studies meeting the eligibility criteria for ovarian (25, 27, 28) and prostate (27, 28, 36) cancer incidence. No statistically significant associations were found between ovarian cancer incidence and ACS guideline adherence in the WHI or NIH-AARP cohorts or WCRF/AICR guideline adherence in the EPIC cohort. Likewise, no significant associations were identified for prostate cancer incidence utilizing the ACS guidelines in the NIH-AARP cohort or the WCRF/AICR guidelines in the EPIC or FOS cohorts.

Discussion

This systematic review included 12 studies from 10 different prospective cohorts evaluating the association between adherence to nutrition and physical activity cancer prevention guidelines and cancer outcomes. High versus low adherence to ACS or WCRF/AICR guidelines was consistently and significantly associated with decreases of 10% to 61% in overall cancer colorectal cancer incidence in both men and women (27%-52%). Consistent reductions were also shown for breast cancer incidence (19-60%), endometrial cancer incidence (23-60%), and colorectal cancer incidence in both men and women (35-52%) for those most adherent to the recommendations. Findings from three studies that reported results for adherence and lung cancer incidence were less clear. No significant relationships were found between adherence and ovarian or prostate cancers.

The greatest evidence for an association with the guidelines was significant findings in seven out of eight studies that included breast cancer incidence as an outcome. Regarding the studies specifically related to breast cancer, all eight included women 50 years and older, although WHI, IWHS, and VITAL cohorts included only postmenopausal women, and the SMC cohort consisted of primarily postmenopausal women. ACS guidelines were employed in the WHI, NIH-AARP, NBSS cohorts while the WCRF/AICR guidelines were used in the VITAL, FOS, SMC, EPIC, IWHS, and NBSS cohorts. Unlike the other studies that compared high adherence to low adherence, the FOS adherence score was evaluated and interpreted in 1-point increments (36). Other differences in the FOS cohort include fewer incident cases of breast cancer (n=124) and inclusion of pre- and postmenopausal women, which may contribute to attenuation of findings.

Significant inverse associations were also found between adherence to the guidelines and colorectal cancer incidence in three out of the four studies reviewed. The inconsistency in the FOS cohort could be due to the difference in the set of guidelines used for generation of adherence score, the different analytic approach utilizing the adherence score as a continuous variable versus a dichotomous variable (high versus low), analyzing men and women together unlike other studies, or perhaps the number of incident cases of colorectal cancer (n=63) in the FOS cohort was too small to detect statistically significant associations.

Less clear were the findings from three studies that included lung cancer as an outcome. One study reported a significant reduction in lung cancer for only men who had high adherence compared to men with low adherence, but not for women. Similarly, a second study found no association for women adhering to the guidelines and lung cancer and a third study had null findings when men and women were reported together. Though smoking status is the strongest risk factor associated with lung cancer, broader health-related behaviors such as diet and physical activity may have a significant role in reducing lung cancer risk in men.

Three studies found an inverse relationship between guideline adherence and risk of endometrial cancer; however, only two of those studies showed a statistically significant result for the high versus low adherence comparison. The third study did suggest a significant trend with higher adherence leading to lower risk of endometrial cancer when the adherence score was evaluated as a continuous variable.

To our knowledge, this is the first systematic review of dietary and physical activity cancer prevention guidelines and cancer outcomes. Strengths of this systematic review include strict inclusion criteria to include only prospective studies that constructed adherence scores to the established cancer prevention guidelines by ACS or WCRF/AICR. All of the studies contained sizeable cohorts with multiple years of follow-up leading to sufficient sample sizes, ample power to detect associations, and sufficient number of outcomes, enabling them to evaluate associations for some site-specific cancers. However, there are also some limitations that must be considered. First, all studies generated their own adherence scores based upon recommendations from either the ACS or WCRF/AICR. Most studies assigned points for meeting or partially meeting recommendations while others categorized adherence as “met” or “did not meet” recommendations. Including multiple levels of exposure may better capture the degree of adherence to the guidelines. Although ACS and WCRF/AICR guidelines are very similar, interpretations of how to measure the recommendations varied. Notably, physical activity was assessed several ways including in metabolic equivalents, times per week, and even a physical activity index. Furthermore, studies utilized frequency questionnaires to capture diet and physical activity data. These self-reported measures are well-known sources of measurement error, which may bias findings toward the null, lending to conservative findings in this review. Components of the adherence score were measured singularly at baseline and used to assess cancer risk over time. Repeated measurements of diet and physical activity may have provided an improved exposure assessment of long-term behavior and risk over time. Follow-up times ranged from 7.7-14 years, which may not be sufficient for assessing the protective role of adherence to nutrition and physical activity cancer prevention guidelines. In addition, although the studies evaluated large cohorts, there was limited population heterogeneity with regard to race or ethnicity, with the exception of the WHI and SCCS studies. Furthermore, analyses varied somewhat among the studies. All studies evaluating associations with ACS guideline adherence made comparisons of high versus low adherence. One study used WCRF/AICR guidelines to compare “met” versus “did not meet” recommendations (29), while a single study evaluated adherence to WCRF/AICR guidelines based upon point increments of the overall score (36). Finally, the potential for publication bias is always of concern. Studies with significant findings are more likely to be published than those with null or unimportant findings. Grey literature was included in the search via Google Scholar in an attempt to capture any work that hasn’t been formally published (abstracts, conference proceedings, etc.). Even though the studies differed in some measurements of individual score components, construction of the adherence score, specifics of the set of guidelines used, and analytic methods, it is important to note that studies generally demonstrated agreement in their findings even across countries with varying diet and physical activity patterns.

In conclusion, strong and consistent evidence from ten large prospective cohorts in 12 publications indicates that adherence to ACS and WCRF/AICR cancer prevention guidelines was associated with significant reductions in cancer incidence and cancer mortality for both men and women. Additionally, significant inverse associations were consistently found between guideline adherence and breast, colorectal, and endometrial cancer incidence. Adherence to a pattern of healthy behaviors, as outlined in cancer prevention guidelines from either the ACS or WCRF/AICR, may reduce cancer incidence and mortality.

Acknowledgments

Financial support: LN Kohler, DJ Roe, and ET Jacobs were supported by NCI Cancer Center Support Grant No. CA023074 at the University of Arizona (PI: Dr. Andrew Kraft, Director, Cancer Center Division, University of Arizona) for this work.

Footnotes

There are no conflicts of interest to disclose.

References

  • 1.Cancer Facts & Figures 2016. American Cancer Society. 2016 [Google Scholar]
  • 2.Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA: a cancer journal for clinicians. 201262:30–67. doi: 10.3322/caac.20140. PubMed PMID: 22237782. [DOI] [PubMed] [Google Scholar]
  • 3.McGinnis JM, Foege WH. Actual causes of death in the United States. Jama. 1993;10270:2207–12. PubMed PMID: 8411605. [PubMed] [Google Scholar]
  • 4.Berger BM, Parton MA, Levin B. USPSTF colorectal cancer screening guidelines: an extended look at multi-year interval testing. The American journal of managed care. 2016;22:e77–81. PubMed PMID: 26881323. [PubMed] [Google Scholar]
  • 5.Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. International journal of cancer Journal international du cancer. PubMed PMID: 11979442. 200299:260–6. doi: 10.1002/ijc.10332. [DOI] [PubMed] [Google Scholar]
  • 6.Willett WC. Balancing life-style and genomics research for disease prevention. Science. 2002296:695–8. doi: 10.1126/science.1071055. PubMed PMID: 11976443. [DOI] [PubMed] [Google Scholar]
  • 7.American Cancer Society. 2015 Available from: http://www.cancer.org.
  • 8.World Cancer Research Fund International. 2015 Available from: http://www.wcrf.org.
  • 9.Spring B, King AC, Pagoto SL, Van Horn L, Fisher JD. Fostering multiple healthy lifestyle behaviors for primary prevention of cancer. The American psychologist. 201570:75–90. doi: 10.1037/a0038806. PubMed PMID: 25730716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of clinical epidemiology. 200962:1006–12. doi: 10.1016/j.jclinepi.2009.06.005. PubMed PMID: 19631508. [DOI] [PubMed] [Google Scholar]
  • 11.Vallance JK, Friedenreich CM, Lavallee CM, Culos-Reed N, Mackey JR, Walley B, et al. Exploring the Feasibility of a Broad-Reach Physical Activity Behavior Change Intervention for Women Receiving Chemotherapy for Breast Cancer: A Randomized Trial. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 201625:391–8. doi: 10.1158/1055-9965.EPI-15-0812. PubMed PMID: 26677207. [DOI] [PubMed] [Google Scholar]
  • 12.World Cancer Research Fund and American Institute for Cancer Research Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective: World Cancer Research Fund and American Institute for Cancer Research. [cited 2014]. Available from: http://www.dietandcancerreport.org/
  • 13.Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer. 2002;94:2490–501. doi: 10.1002/cncr.101970. PubMed PMID: 12015775. [DOI] [PubMed] [Google Scholar]
  • 14.Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Controlled clinical trials. 199819:61–109. doi: 10.1016/s0197-2456(97)00078-0. PubMed PMID: 9492970. [DOI] [PubMed] [Google Scholar]
  • 15.Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. American journal of epidemiology. 2001154:1119–25. doi: 10.1093/aje/154.12.1119. PubMed PMID: 11744517. [DOI] [PubMed] [Google Scholar]
  • 16.Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP. The Framingham Offspring Study. Design and preliminary data. Preventive medicine. 19754:518–25. doi: 10.1016/0091-7435(75)90037-7. PubMed PMID: 1208363. [DOI] [PubMed] [Google Scholar]
  • 17.White E, Patterson RE, Kristal AR, Thornquist M, King I, Shattuck AL, et al. VITamins And Lifestyle cohort study: study design and characteristics of supplement users. American journal of epidemiology. 2004159:83–93. doi: 10.1093/aje/kwh010. PubMed PMID: 14693663. [DOI] [PubMed] [Google Scholar]
  • 18.Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Annals of internal medicine. 2002137:305–12. doi: 10.7326/0003-4819-137-5_part_1-200209030-00005. PubMed PMID: 12204013. [DOI] [PubMed] [Google Scholar]
  • 19.Wolk A, Larsson SC, Johansson JE, Ekman P. Long-term fatty fish consumption and renal cell carcinoma incidence in women. Jama. 2006296:1371–6. doi: 10.1001/jama.296.11.1371. PubMed PMID: 16985229. [DOI] [PubMed] [Google Scholar]
  • 20.Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public health nutrition. 20025:1113–24. doi: 10.1079/PHN2002394. PubMed PMID: 12639222. [DOI] [PubMed] [Google Scholar]
  • 21.Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. International journal of epidemiology. 1997;26(Suppl 1):S6–14. doi: 10.1093/ije/26.suppl_1.s6. PubMed PMID: 9126529. [DOI] [PubMed] [Google Scholar]
  • 22.Signorello LB, Hargreaves MK, Steinwandel MD, Zheng W, Cai Q, Schlundt DG, et al. Southern community cohort study: establishing a cohort to investigate health disparities. Journal of the National Medical Association. 200597:972–9. PubMed PMID: 16080667. Pubmed Central PMCID: 2569308. [PMC free article] [PubMed] [Google Scholar]
  • 23.Folsom AR, Kaye SA, Potter JD, Prineas RJ. Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: early findings of the Iowa Women's Health Study. Cancer research. 198949:6828–31. PubMed PMID: 2819722. [PubMed] [Google Scholar]
  • 24.McCullough ML, Patel AV, Kushi LH, Patel R, Willett WC, Doyle C, et al. Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 201120:1089–97. doi: 10.1158/1055-9965.EPI-10-1173. PubMed PMID: 21467238. [DOI] [PubMed] [Google Scholar]
  • 25.Thomson CA, McCullough ML, Wertheim BC, Chlebowski RT, Martinez ME, Stefanick ML, et al. Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women's health initiative. Cancer prevention research. 20147:42–53. doi: 10.1158/1940-6207.CAPR-13-0258. PubMed PMID: 24403289. Pubmed Central PMCID: 4090781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Warren Andersen S, Blot WJ, Shu XO, Sonderman JS, Steinwandel MD, Hargreaves MK, et al. Adherence to cancer prevention guidelines and cancer risk in low-income and African American populations. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016 Mar 10; doi: 10.1158/1055-9965.EPI-15-1186. PubMed PMID: 26965499. Epub 2016/03/12. Eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kabat GC, Matthews CE, Kamensky V, Hollenbeck AR, Rohan TE. Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality: a prospective cohort study. The American journal of clinical nutrition. 2015101:558–69. doi: 10.3945/ajcn.114.094854. PubMed PMID: 25733641. Pubmed Central PMCID: PMC4340061. Epub 2015/03/04. eng. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Romaguera D, Vergnaud AC, Peeters PH, van Gils CH, Chan DS, Ferrari P, et al. Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. The American journal of clinical nutrition. 201296:150–63. doi: 10.3945/ajcn.111.031674. PubMed PMID: 22592101. [DOI] [PubMed] [Google Scholar]
  • 29.Hastert TA, Beresford SA, Sheppard L, White E. Adherence to the WCRF/AICR cancer prevention recommendations and cancer-specific mortality: results from the Vitamins and Lifestyle (VITAL) Study. Cancer causes & control : CCC. 201425:541–52. doi: 10.1007/s10552-014-0358-6. PubMed PMID: 24557428. Pubmed Central PMCID: PMC4009723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Vergnaud AC, Romaguera D, Peeters PH, van Gils CH, Chan DS, Romieu I, et al. Adherence to the World Cancer Research Fund/American Institute for Cancer Research guidelines and risk of death in Europe: results from the European Prospective Investigation into Nutrition and Cancer cohort study1,4. The American journal of clinical nutrition. 201397:1107–20. doi: 10.3945/ajcn.112.049569. PubMed PMID: 23553166. [DOI] [PubMed] [Google Scholar]
  • 31.Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of epidemiology. 2003;13:S122–8. doi: 10.1016/s1047-2797(03)00048-6. PubMed PMID: 14575944. [DOI] [PubMed] [Google Scholar]
  • 32.Hastert TA, Beresford SA, Patterson RE, Kristal AR, White E. Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 201322:1498–508. doi: 10.1158/1055-9965.EPI-13-0210. PubMed PMID: 23780838. Pubmed Central PMCID: PMC3774119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Harris HR, Bergkvist L, Wolk A. Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations and breast cancer risk. International Journal of Cancer. 2016 doi: 10.1002/ijc.30015. [DOI] [PubMed] [Google Scholar]
  • 34.Catsburg C, Miller AB, Rohan TE. Adherence to cancer prevention guidelines and risk of breast cancer. International journal of cancer. 2014135:2444–52. doi: 10.1002/ijc.28887. PubMed PMID: 24723234. [DOI] [PubMed] [Google Scholar]
  • 35.Nomura SJ, Inoue-Choi M, Lazovich D, Robien K. WCRF/AICR recommendation adherence and breast cancer incidence among postmenopausal women with and without non-modifiable risk factors. International journal of cancer Journal international du cancer. 2016 Jan 12; doi: 10.1002/ijc.29994. PubMed PMID: 26756307. Epub 2016/01/13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Makarem N, Lin Y, Bandera EV, Jacques PF, Parekh N. Concordance with World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) guidelines for cancer prevention and obesity-related cancer risk in the Framingham Offspring cohort (1991-2008) Cancer causes & control : CCC. 201526:277–86. doi: 10.1007/s10552-014-0509-9. PubMed PMID: 25559553. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES